Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe clinical programs — 1032 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

United Therapeutics Europe projects

1,032 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.

United Therapeutics Europe has 1,032 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,032 programs

Clinical programs

Page 13 of 22

  1. D1ME100 (dengue-1 premembrane/envelope DNA vaccine)

    United Therapeutics Europe Ltd

    Dengue

    phase 1 mab completed

    1 trial

  2. DFUPS

    United Therapeutics Europe Ltd

    Diabetic Foot

    phase 1 other completed

    1 trial

  3. DMPA

    United Therapeutics Europe Ltd

    Contraception

    phase 1 small molecule completed

    1 trial

  4. DSM265

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  5. DT2216

    United Therapeutics Europe Ltd

    Ovarian Cancer

    phase 1 small molecule active

    1 trial

  6. Dasatinib

    United Therapeutics Europe Ltd

    Malignant Pleural Mesothelioma

    phase 1 small molecule completed

    1 trial

  7. Decision Aid

    United Therapeutics Europe Ltd

    Chronic Kidney Failure

    phase 1 other completed

    1 trial

  8. Dendritic Cell Vaccine

    United Therapeutics Europe Ltd

    Leptomeningeal Disease

    phase 1 mab active

    1 trial

  9. Dinutuximab

    United Therapeutics Europe Ltd

    Neuroblastoma

    phase 1 small molecule active

    2 trials

  10. Docetaxel

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 1 small molecule completed

    1 trial

  11. Doxorubicin

    United Therapeutics Europe Ltd

    Pancreatic Ductal Adenocarcinoma

    phase 1 small molecule terminated

    1 trial

  12. EVOLVE104

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 1 small molecule active

    1 trial

  13. Ebola Vaccine - low dose

    United Therapeutics Europe Ltd

    Ebola Virus Disease

    phase 1 mab completed

    1 trial

  14. Emtricitabine

    United Therapeutics Europe Ltd

    HIV

    phase 1 small molecule completed

    1 trial

  15. Encapsulated Calcium

    United Therapeutics Europe Ltd

    Pregnancy

    phase 1 other completed

    1 trial

  16. Endo Tool

    United Therapeutics Europe Ltd

    Burns

    phase 1 other completed

    1 trial

  17. Etanercept

    United Therapeutics Europe Ltd

    Gulf War Illness

    phase 1 small molecule active

    1 trial

  18. External non-invasive stimulation

    United Therapeutics Europe Ltd

    TBI (Traumatic Brain Injury)

    phase 1 other active

    1 trial

  19. FGI-101-1A6

    United Therapeutics Europe Ltd

    Influenza

    phase 1 small molecule active

    1 trial

  20. FMP012 with AS01B adjuvant system

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  21. FMP1/AS02A

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  22. Gallium-68 citrate

    United Therapeutics Europe Ltd

    Prostatic Neoplasms

    phase 1 small molecule completed

    1 trial

  23. Glucagon

    United Therapeutics Europe Ltd

    Type 1 Diabetes Mellitus With Hypoglycemia

    phase 1 small molecule completed

    1 trial

  24. Glucose

    United Therapeutics Europe Ltd

    Diabetes Mellitus

    phase 1 other completed

    1 trial

  25. Glyburide

    United Therapeutics Europe Ltd

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  26. Granulocyte Colony-Stimulating Factor

    United Therapeutics Europe Ltd

    Biliary Atresia

    phase 1 small molecule completed

    1 trial

  27. Group 1: 10 ug FMP012 with 2 ug GLA-SE

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  28. Group A Deactivated TENS with beeping sound (15-second interval)

    United Therapeutics Europe Ltd

    Healthy

    phase 1 other completed

    1 trial

  29. Guadecitabine

    United Therapeutics Europe Ltd

    Non Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  30. Human interferon alfa 1b inhalation solution

    United Therapeutics Europe Ltd

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  31. Hyperpolarized xenon

    United Therapeutics Europe Ltd

    Lung Disease

    phase 1 small molecule completed

    1 trial

  32. IMM-BCP-01

    United Therapeutics Europe Ltd

    SARS-CoV2 Infection

    phase 1 small molecule terminated

    1 trial

  33. ITX 5061

    United Therapeutics Europe Ltd

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  34. Ibuprofen

    United Therapeutics Europe Ltd

    Tonsillectomy With or Without Adenoidectomy

    phase 1 small molecule terminated

    1 trial

  35. Ibuprofen 800 mg

    United Therapeutics Europe Ltd

    Bone Resorption

    phase 1 small molecule completed

    1 trial

  36. Image Guided Dynamic Dosimetry

    United Therapeutics Europe Ltd

    Locally Confined Adenocarcinoma of the Prostate

    phase 1 other completed

    1 trial

  37. Imatimib Mesylate

    United Therapeutics Europe Ltd

    Lymphangioleiomyomatosis (LAM)

    phase 1 small molecule active

    1 trial

  38. Influenza A/California/04/09

    United Therapeutics Europe Ltd

    Influenza A

    phase 1 mab active

    1 trial

  39. Influenza A/Texas/71/2017 (H3N2)

    United Therapeutics Europe Ltd

    Influenza Viral Infections

    phase 1 mab completed

    1 trial

  40. Intravenous Artesunate

    United Therapeutics Europe Ltd

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  41. Itraconazole

    United Therapeutics Europe Ltd

    Non-small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  42. KRAS Vaccine with Poly-ICLC adjuvant

    United Therapeutics Europe Ltd

    Colorectal Cancer

    phase 1 small molecule active

    1 trial

  43. Ketamine

    United Therapeutics Europe Ltd

    Acute Depression

    phase 1 small molecule terminated

    1 trial

  44. Ketorolac

    United Therapeutics Europe Ltd

    Pain, Post-operative

    phase 1 small molecule completed

    1 trial

  45. LS11

    United Therapeutics Europe Ltd

    Neurofibroma

    phase 1 small molecule terminated

    1 trial

  46. Leukocyte Interleukin, Injection 200IU

    United Therapeutics Europe Ltd

    Condyloma

    phase 1 small molecule terminated

    1 trial

  47. Liposomal bupivacaine

    United Therapeutics Europe Ltd

    Pain, Postoperative

    phase 1 small molecule completed

    1 trial

  48. Losartan potassium

    United Therapeutics Europe Ltd

    Emotional Processing

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does United Therapeutics Europe have?

1,032 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.